SmartQuit app

2Morrow’s smoking cessation app SmartQuit heading to Turkey

Together with mHealth Technologies, 2Morrow will localize the SmartQuit app to help about 14 million people in Turkey (as of 2013) kick the habit.
VerbalCare

MSD acquires VerbalCare to improve patient-doctor communication

Founded in 2013, VerbalCare closes the communication gap between patients and caregivers by providing a mobile tool to improve the quality of patient care.
Apple Watch

Apple Watch was the second best-selling wearable last quarter

In the period between April and June, the iPhone maker has sold 3.6 million units of the Apple Watch, representing 20 percent of all wearables shipped.
Hardware for Health

J&J, PCH launch an accelerator for consumer health hardware

Companies accepted to the program will benefit from the free office space and funding, as well as marketing and legal consulting services.
DiabetesGuru

Sweden-based Diabetes Tools acquiring DiabetesGuru app

Under the deal, Diabetes Tools will get all rights for the app, while still allowing the developer behind DiabetesGuru to support the project with advice.
Chrono Therapeutics

Chrono Therapeutics receives second Fast Track SBIR grant from the NCI

The award of up to $2.3M will support final product development of the digital portion of Chrono's patient-individualized smoking cessation therapy.
CVS Health

CVS Health teams-up American Well, Doctor On Demand and Teladoc to improve patient care

The company is testing different telehealth opportunities, including making telehealth physician care accessible through its digital properties.
MOCAheart consumer health monitor

MOCACARE raises $4M for its MOCAheart consumer health monitor

The device is set to ship in September, providing users with an easy way to monitor their cardiovascular health, without the need for cuffs or monitors.
Health Wildcatters

Health Wildcatters adds 10 digital health startups to its accelerator

Each of the selected companies will participate in the 12 mentorship week program, and receive $30,000 in exchange for 8% equity stake.
HealthWatch

HealthWatch’s MasterCaution Device clears the FDA hurdle

The agency cleared it as a Class II medical device intended to condition electrocardiogram (ECG) signals for digital transmission via Bluetooth.